The role of androgens and the androgen receptor in cycling endometrium

Molecular and Cellular Endocrinology

Volumn 358, Issue 2, 2012, Pages 166-175

  Cloke, Brianna ^a   Christian, Mark ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Androgen; Androgen receptor; Endometrium; Fertility

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; ANDROSTENEDIONE; CHORIONIC GONADOTROPIN; CYPROTERONE ACETATE; ESTROGEN RECEPTOR; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; PRASTERONE; PRASTERONE SULFATE; PROGESTERONE; PROGESTERONE RECEPTOR; TESTOSTERONE;

ANDROGEN SYNTHESIS; BIOTRANSFORMATION; CELL DIFFERENTIATION; CELL TYPE; CONCEPTION; DECIDUAL CELL; DECIDUALIZATION; EARLY SECRETORY PHASE; ENDOMETRIUM; FERTILIZATION IN VITRO; HIRSUTISM; HORMONE SUBSTITUTION; HUMAN; LATE SECRETORY PHASE; MATERNAL AGE; MENSTRUAL CYCLE; NIDATION; NONHUMAN; ORAL CONTRACEPTION; OVARY POLYCYSTIC DISEASE; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PROLIFERATIVE PHASE; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL;

ANDROGENS; ANIMALS; ENDOMETRIUM; FEMALE; HUMANS; MENSTRUAL CYCLE; RECEPTORS, ANDROGEN; REPRODUCTION; SIGNAL TRANSDUCTION;

EID: 84861528489     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.06.031     Document Type: Review

References (141)

1. Abdalla H.I., Billett A., Kan A.K., Baig S., Wren M., Korea L., Studd J.W. Obstetric outcome in 232 ovum donation pregnancies. Br. J. Obstet. Gynaecol. 1998, 105:332-337.
2. Apparao K.B., Lovely L.P., Gui Y., Lininger R.A., Lessey B.A. Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biol. Reprod. 2002, 66:297-304.
3. Barad D., Brill H., Gleicher N. Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. J. Assist. Reprod. Genet. 2007, 24:629-634.
4. Bell S.C., Jackson J.A., Ashmore J., Zhu H.H., Tseng L. Regulation of insulin-like growth factor-binding protein-1 synthesis and secretion by progestin and relaxin in long term cultures of human endometrial stromal cells. J. Clin. Endocrinol. Metab. 1991, 72:1014-1024.
5. Blaha G.C. Effects of age, treatment, and method of induction on deciduomata in the golden hamster. Fertil. Steril. 1967, 18:477-485.
6. Blok L.J., Themmen A.P., Peters A.H., Trapman J., Baarends W.M., Hoogerbrugge J.W., Grootegoed J.A. Transcriptional regulation of androgen receptor gene expression in Sertoli cells and other cell types. Mol. Cell Endocrinol. 1992, 88:153-164.
7. Bonney R.C., Scanlon M.J., Jones D.L., Reed M.J., James V.H. Adrenal androgen concentrations in endometrium and plasma during the menstrual cycle. J. Endocrinol. 1984, 101:181-188.
8. Boomsma C.M., Fauser B.C., Macklon N.S. Pregnancy complications in women with polycystic ovary syndrome. Semin. Reprod. Med. 2008, 26:72-84.
9. Brar A.K., Frank G.R., Richards R.G., Meyer A.J., Kessler C.A., Cedars M.I., Klein D.J., Handwerger S. Laminin decreases PRL and IGFBP-1 expression during in vitro decidualization of human endometrial stromal cells. J. Cell Physiol. 1995, 163:30-37.
10. Brar A.K., Handwerger S., Kessler C.A., Aronow B.J. Gene induction and categorical reprogramming during in vitro human endometrial fibroblast decidualization. Physiol. Genomics 2001, 7:135-148.
11. Braunstein G.D., Horton R. Increased maternal serum 3 alpha, 17 beta-androstanediol glucuronide concentrations during pregnancy. Fertil. Steril. 1985, 44:210-213.
12. Brooks A.A., Johnson M.R., Hills F., Chard T., Irvine R., Abdalla H.I. Insulin-related growth factor binding protein-1 levels in ovum donation pregnancies. Eur. J. Obstet. Gynecol. Reprod. Biol. 1995, 59:91-94.
13. Brosens I., Robertson W.B., Dixon H.G. The physiological response of the vessels of the placental bed to normal pregnancy. J. Pathol. Bacteriol. 1967, 93:569-579.
14. Brosens J.J., Hayashi N., White J.O. Progesterone receptor regulates decidual prolactin expression in differentiating human endometrial stromal cells. Endocrinology 1999, 140:4809-4820.
15. Brosens J.J., Pijnenborg R., Brosens I.A. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am. J. Obstet. Gynecol. 2002, 187:1416-1423.
16. Brosens I.A., De Sutter P., Hamerlynck T., Imeraj L., Yao Z., Cloke B., Brosens J.J., Dhont M. Endometriosis is associated with a decreased risk of pre-eclampsia. Hum. Reprod. 2007, 22:1725-1729.
17. Burger H.G. Androgen production in women. Fertil. Steril. 2002, 77(Suppl. 4):S3-S5.
18. Callewaert L., Verrijdt G., Haelens A., Claessens F. Differential effect of small ubiquitin-like modifier (SUMO)-ylation of the androgen receptor in the control of cooperativity on selective versus canonical response elements. Mol. Endocrinol. 2004, 18:1438-1449.
19. Cano F., Simon C., Remohi J., Pellicer A. Effect of aging on the female reproductive system: evidence for a role of uterine senescence in the decline in female fecundity. Fertil. Steril. 1995, 64:584-589.
20. Carlsen S.M., Jacobsen G., Bjerve K.S. Androgen levels in pregnant women decrease with increasing maternal age. Scand. J. Clin. Lab Invest. 2003, 63:23-26.
21. Castracane V.D., Asch R.H. Testosterone and androstenedione in premature ovarian failure pregnancies: evidence for an ovarian source of androgens in early pregnancy. Hum. Reprod. 1995, 10:677-680.
22. Cermik D., Selam B., Taylor H.S. Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2003, 88:238-243.
23. Chandrasekhar Y., Armstrong D.T., Kennedy T.G. Implantation delay and anti-deciduogenic activity in the rat by the anti-androgen, hydroxyflutamide. Biol. Reprod. 1990, 42:120-125.
24. Cleary-Goldman J., Malone F.D., Vidaver J., Ball R.H., Nyberg D.A., Comstock C.H., Saade G.R., Eddleman K.A., Klugman S., Dugoff L., Timor-Tritsch I.E., Craigo S.D., Carr S.R., Wolfe H.M., Bianchi D.W., D'Alton M. Impact of maternal age on obstetric outcome. Obstet. Gynecol. 2005, 105:983-990.
25. Cloke B., Huhtinen K., Fusi L., Kajihara T., Yliheikkila M., Ho K.K., Teklenburg G., Lavery S., Jones M.C., Trew G., Kim J.J., Lam E.W., Cartwright J.E., Poutanen M., Brosens J.J. The androgen and progesterone receptors regulate distinct gene networks and cellular functions in decidualizing endometrium. Endocrinology 2008, 149:4462-4474.
26. Cloke B., Shah K., Kaneda H., Lavery S., Trew G., Fusi L., Higham J., Dina R.E., Ghaem-Maghami S., Ellis P., Brosens J.J., Christian M. The poly(c)-binding protein-1 regulates expression of the androgen receptor. Endocrinology 2010, 151:3954-3964.
27. Craig S.S., Jollie W.P. Age changes in density of endometrial stromal cells of the rat. Exp. Gerontol. 1985, 20:93-97.
28. Critchley H.O., Wang H., Jones R.L., Kelly R.W., Drudy T.A., Gebbie A.E., Buckley C.H., McNeilly A.S., Glasier A.F. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery. Hum. Reprod. 1998, 13:1218-1224.
29. Dai J.L., Burnstein K.L. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA. Mol. Endocrinol. 1996, 10:1582-1594.
30. Davison S.L., Bell R., Donath S., Montalto J.G., Davis S.R. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J. Clin. Endocrinol. Metab. 2005, 90:3847-3853.
31. Dawood M.Y., Saxena B.B. Plasma testosterone and dihydrotestosterone in ovulatory and anovulatory cycles. Am. J. Obstet. Gynecol. 1976, 126:430-435.
32. Dommisse J., Tiltman A.J. Placental bed biopsies in placental abruption. Br. J. Obstet. Gynaecol. 1992, 99:651-654.
33. Draper E.S., Kurinczuk J.J., Abrams K.R., Clarke M. Assessment of separate contributions to perinatal mortality of infertility history and treatment: a case-control analysis. Lancet 1999, 353:1746-1749.
34. Dreyfuss G., Kim V.N., Kataoka N. Messenger-RNA-binding proteins and the messages they carry. Nat. Rev. Mol. Cell Biol. 2002, 3:195-205.
35. Ehrmann D.A. Polycystic ovary syndrome. N. Engl. J. Med. 2005, 352:1223-1236.
36. Erel C.T., Aydin Y., Kaleli S., Ilvan S., Senturk L.M. Is endometrial apoptosis evidence of endometrial aging in unexplained infertility? a preliminary report. Eur. J. Obstet. Gynecol. Reprod. Biol. 2005, 121:195-201.
37. Finn C.A., Martin L. The cellular response of the uterus of the aged mouse to oestrogen and progesterone. J. Reprod. Fertil. 1969, 20:545-547.
38. Frattarelli J.L., Peterson E.H. Effect of androgen levels on in vitro fertilization cycles. Fertil. Steril. 2004, 81:1713-1714.
39. Frolich M., Brand E.C., van Hall E.V. Serum levels of unconjugated aetiocholanolone androstenedione, testosterone, dehydroepiandrosterone, aldosterone, progesterone and oestrogens during the normal menstrual cycle. Acta Endocrinol. (Copenh) 1976, 81:548-562.
40. Gellersen B., Brosens I.A., Brosens J.J. Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives. Semin. Reprod. Med. 2007, 25:445-453.
41. Ghazi H.A., Spielberger C., Kallen B. Delivery outcome after infertility - a registry study. Fertil. Steril. 1991, 55:726-732.
42. Gonzalez-Diddi M., Komisaruk B., Beyer C. Differential effects of testosterone and dihydrotestosterone on the diverse uterine tissues of the ovariectomized rat. Endocrinology 1972, 91:1129-1132.
43. Gregory C.W., Wilson E.M., Apparao K.B., Lininger R.A., Meyer W.R., Kowalik A., Fritz M.A., Lessey B.A. Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J. Clin. Endocrinol. Metab. 2002, 87:2960-2966.
44. Grewal S., Carver J.G., Ridley A.J., Mardon H.J. Implantation of the human embryo requires Rac1-dependent endometrial stromal cell migration. Proc. Natl. Acad. Sci. USA 2008, 105:16189-16194.
45. Guay A., Munarriz R., Jacobson J., Talakoub L., Traish A., Quirk F., Goldstein I., Spark R. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part A. Serum androgen levels in women aged 20-49years with no complaints of sexual dysfunction. Int. J. Impot. Res. 2004, 16:112-120.
46. Guerrero R., Landgren B.M., Montiel R., Cekan Z., Diczfalusy E. Unconjugated steroids in the human endometrium. Contraception 1975, 11:169-177.
47. Habiba M.A., Bell S.C., Al-Azzawi F. Endometrial responses to hormone replacement therapy: histological features compared with those of late luteal phase endometrium. Hum. Reprod. 1998, 13:1674-1682.
48. Hackenberg R., Beck S., Filmer A., Hushmand Nia A., Kunzmann R., Koch M., Slater E.P., Schulz K.D. Androgen responsiveness of the new human endometrial cancer cell line MFE-296. Int. J. Cancer 1994, 57:117-122.
49. Hagler S., Schultz A., Hankin H., Kunstadter R.H. Fetal effects of steroid therapy during pregnancy. Am. J. Dis. Child. 1963, 106:586-590.
50. Harada M., Osuga Y., Takemura Y., Yoshino O., Koga K., Hirota Y., Hirata T., Morimoto C., Yano T., Taketani Y. Mechanical stretch upregulates IGFBP-1 secretion from decidualized endometrial stromal cells. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E268-272.
51. Harrison R.F., Mansfield M.D. Maternal plasma androgens in early human pregnancy. Br. J. Obstet. Gynaecol. 1980, 87:695-704.
52. Hartmann B.W., Kirchengast S., Albrecht A., Laml T., Soregi G., Huber J.C. Androgen serum levels in women with premature ovarian failure compared to fertile and menopausal controls. Gynecol. Obstet. Invest. 1997, 44:127-131.
53. Hausknecht V., Lopez de la Osa E., Gurpide E. In vitro metabolism of C19 steroids in human endometrium. J. Steroid Biochem. 1982, 17:621-629.
54. Hines M., Golombok S., Rust J., Johnston K.J., Golding J. Testosterone during pregnancy and gender role behavior of preschool children: a longitudinal, population study. Child Dev. 2002, 73:1678-1687.
55. Hofmann G.E., Thie J., Scott R.T., Navot D. Endometrial thickness is predictive of histologic endometrial maturation in women undergoing hormone replacement for ovum donation. Fertil. Steril. 1996, 66:380-383.
56. Horie K., Takakura K., Imai K., Liao S., Mori T. Immunohistochemical localization of androgen receptor in the human endometrium, decidua, placenta and pathological conditions of the endometrium. Hum. Reprod. 1992, 7:1461-1466.
57. Hu Y.C., Wang P.H., Yeh S., Wang R.S., Xie C., Xu Q., Zhou X., Chao H.T., Tsai M.Y., Chang C. Subfertility and defective folliculogenesis in female mice lacking androgen receptor. Proc. Natl. Acad. Sci. USA 2004, 101:11209-11214.
58. Hu S.J., Ren G., Liu J.L., Zhao Z.A., Yu Y.S., Su R.W., Ma X.H., Ni H., Lei W., Yang Z.M. MicroRNA expression and regulation in mouse uterus during embryo implantation. J. Biol. Chem. 2008, 283:23473-23484.
59. Ito K., Suzuki T., Akahira J., Moriya T., Kaneko C., Utsunomiya H., Yaegashi N., Okamura K., Sasano H. Expression of androgen receptor and 5alpha-reductases in the human normal endometrium and its disorders. Int. J. Cancer 2002, 99:652-657.
60. Jacobson B.D. Hazards of norethindrone therapy during pregnancy. Am. J. Obstet. Gynecol. 1962, 84:962-968.
61. Jacobsson B., Ladfors L., Milsom I. Advanced maternal age and adverse perinatal outcome. Obstet. Gynecol. 2004, 104:727-733.
62. Jones M.C., Fusi L., Higham J.H., Abdel-Hafiz H., Horwitz K.B., Lam E.W., Brosens J.J. Regulation of the SUMO pathway sensitizes differentiating human endometrial stromal cells to progesterone. Proc. Natl. Acad. Sci. USA 2006, 103:16272-16277.
63. Kalantaridou S.N., Davis S.R., Nelson L.M. Premature ovarian failure. Endocrinol. Metab. Clin. North Am. 1998, 27:989-1006.
64. Kalantaridou S.N., Calis K.A., Vanderhoof V.H., Bakalov V.K., Corrigan E.C., Troendle J.F., Nelson L.M. Testosterone deficiency in young women with 46, XX spontaneous premature ovarian failure. Fertil. Steril. 2006, 86:1475-1482.
65. Kang Z., Pirskanen A., Janne O.A., Palvimo J.J. Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J. Biol. Chem. 2002, 277:48366-48371.
66. Katz Z., Lancet M., Skornik J., Chemke J., Mogilner B.M., Klinberg M. Teratogenicity of progestogens given during the first trimester of pregnancy. Obstet. Gynecol. 1985, 65:775-780.
67. Keegan D.A., Krey L.C., Chang H.C., Noyes N. Increased risk of pregnancy-induced hypertension in young recipients of donated oocytes. Fertil. Steril. 2007, 87:776-781.
68. Khong T.Y., De Wolf F., Robertson W.B., Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br. J. Obstet. Gynaecol. 1986, 93:1049-1059.
69. Kononen J., Bubendorf L., Kallioniemi A., Barlund M., Schraml P., Leighton S., Torhorst J., Mihatsch M.J., Sauter G., Kallioniemi O.P. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 1998, 4:844-847.
70. Kumar R.C., Thakur M.K. Sex steroids reduce DNaseI accessibility of androgen receptor promoter in adult male mice brain. Brain Res. Mol. Brain Res. 2004, 131:1-7.
71. Labrie F., Belanger A., Cusan L., Candas B. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J. Clin. Endocrinol. Metab. 1997, 82:2403-2409.
72. Labrie F., Belanger A., Cusan L., Gomez J.L., Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J. Clin. Endocrinol. Metab. 1997, 82:2396-2402.
73. Labrie F., Luu-The V., Labrie C., Belanger A., Simard J., Lin S.X., Pelletier G. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr. Rev. 2003, 24:152-182.
74. Li T.C., Aplin J.D., Warren A., Graham R.A., Dockery P., Cooke I.D. Endometrial responses to three different progestins in artificial cycles: a prospective, crossover study. Fertil. Steril. 1994, 62:191-193.
75. Li Y., Isomaa V., Pulkka A., Herva R., Peltoketo H., Vihko P. Expression of 3beta-hydroxysteroid dehydrogenase type 1, P450 aromatase, and 17beta-hydroxysteroid dehydrogenase types 1,2,5 and 7 mRNAs in human early and mid-gestation placentas. Placenta 2005, 26:387-392.
76. Lim H., Paria B.C., Das S.K., Dinchuk J.E., Langenbach R., Trzaskos J.M., Dey S.K. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 1997, 91:197-208.
77. Lin H.K., Altuwaijri S., Lin W.J., Kan P.Y., Collins L.L., Chang C. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells. J. Biol. Chem. 2002, 277:36570-36576.
78. Loeser A.A. The action of testosterone propionate on the uterus and breast. Lancet 1938, 12:373-374.
79. Lovely L.P., Appa Rao K.B., Gui Y., Lessey B.A. Characterization of androgen receptors in a well-differentiated endometrial adenocarcinoma cell line (Ishikawa). J. Steroid Biochem. Mol. Biol. 2000, 74:235-241.
80. Lutjen P., Trounson A., Leeton J., Findlay J., Wood C., Renou P. The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature 1984, 307:174-175.
81. Lynch V.J., Tanzer A., Wang Y., Leung F.C., Gellersen B., Emera D., Wagner G.P. Adaptive changes in the transcription factor HoxA-11 are essential for the evolution of pregnancy in mammals. Proc. Natl. Acad. Sci. USA 2008, 105:14928-14933.
82. Maccario M., Mazza E., Ramunni J., Oleandri S.E., Savio P., Grottoli S., Rossetto R., Procopio M., Gauna C., Ghigo E. Relationships between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women. Clin. Endocrinol. (Oxf) 1999, 50:595-600.
83. Mamas L., Mamas E. Premature ovarian failure and dehydroepiandrosterone. Fertil. Steril. 2009, 91:644-646.
84. McGrath M., Lee I.M., Hankinson S.E., Kraft P., Hunter D.J., Buring J., De Vivo I. Androgen receptor polymorphisms and endometrial cancer risk. Int. J. Cancer 2006, 118:1261-1268.
85. Meister G. MiRNAs get an early start on translational silencing. Cell 2007, 131:25-28.
86. Mertens H.J., Heineman M.J., Koudstaal J., Theunissen P., Evers J.L. Androgen receptor content in human endometrium. Eur. J. Obstet. Gynecol. Reprod. Biol. 1996, 70:11-13.
87. Mertens H.J., Heineman M.J., Theunissen P.H., de Jong F.H., Evers J.L. Androgen, estrogen and progesterone receptor expression in the human uterus during the menstrual cycle. Eur. J. Obstet. Gynecol. Reprod. Biol. 2001, 98:58-65.
88. Moll E., van der Veen F., van Wely M. The role of metformin in polycystic ovary syndrome: a systematic review. Hum. Reprod. Update 2007, 13:527-537.
89. Mueller A., Kiesewetter F., Binder H., Beckmann M.W., Dittrich R. Long-term administration of testosterone undecanoate every 3months for testosterone supplementation in female-to-male transsexuals. J. Clin. Endocrinol. Metab. 2007, 92:3470-3475.
90. Mulac-Jericevic B., Mullinax R.A., DeMayo F.J., Lydon J.P., Conneely O.M. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 2000, 289:1751-1754.
91. Muratani M., Tansey W.P. How the ubiquitin-proteasome system controls transcription. Nat. Rev. Mol. Cell Biol. 2003, 4:192-201.
92. Mushayandebvu T., Castracane V.D., Gimpel T., Adel T., Santoro N. Evidence for diminished midcycle ovarian androgen production in older reproductive aged women. Fertil. Steril. 1996, 65:721-723.
93. Narvekar N., Cameron S., Critchley H.O., Lin S., Cheng L., Baird D.T. Low-dose mifepristone inhibits endometrial proliferation and up-regulates androgen receptor. J. Clin. Endocrinol. Metab. 2004, 89:2491-2497.
94. Nelson V.L., Legro R.S., Strauss J.F., McAllister J.M. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol. Endocrinol. 1999, 13:946-957.
95. Nestler J.E., Jakubowicz D.J., Evans W.S., Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N. Engl. J. Med. 1998, 338:1876-1880.
96. Orentreich N., Brind J.L., Rizer R.L., Vogelman J.H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrinol. Metab. 1984, 59:551-555.
97. Ostling P., Leivonen S.K., Aakula A., Kohonen P., Makela R., Hagman Z., Edsjo A., Kangaspeska S., Edgren H., Nicorici D., Bjartell A., Ceder Y., Perala M., Kallioniemi O. Systematic analysis of micrornas targeting the androgen receptor in prostate cancer Cells. Cancer Res. 2011, 71:1956-1967.
98. Pados G., Camus M., Van Steirteghem A., Bonduelle M., Devroey P. The evolution and outcome of pregnancies from oocyte donation. Hum. Reprod. 1994, 9:538-542.
99. Phillips V., Graham C.T., Manek S., McCluggage W.G. The effects of the levonorgestrel intrauterine system (Mirena coil) on endometrial morphology. J. Clin. Pathol. 2003, 56:305-307.
100. Pijnenborg R., Anthony J., Davey D.A., Rees A., Tiltman A., Vercruysse L., van Assche A. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br. J. Obstet. Gynaecol. 1991, 98:648-655.
101. Popovici R.M., Kao L.C., Giudice L.C. Discovery of new inducible genes in in vitro decidualized human endometrial stromal cells using microarray technology. Endocrinology 2000, 141:3510-3513.
102. Poukka H., Karvonen U., Janne O.A., Palvimo J.J. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc. Natl. Acad. Sci. USA 2000, 97:14145-14150.
103. Pratt W.B., Galigniana M.D., Morishima Y., Murphy P.J. Role of molecular chaperones in steroid receptor action. Essays Biochem. 2004, 40:41-58.
104. Prost O., Adessi G.L. Estrone and dehydroepiandrosterone sulfatase activities in normal and pathological human endometrium biopsies. J. Clin. Endocrinol. Metab. 1983, 56:653-661.
105. Qiao J., Wang L., Li R., Zhang X. Microarray evaluation of endometrial receptivity in Chinese women with polycystic ovary syndrome. Reprod. Biomed. Online 2008, 17:425-435.
106. Quezada S., Avellaira C., Johnson M.C., Gabler F., Fuentes A., Vega M. Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome. Fertil. Steril. 2006, 85:1017-1026.
107. Reddy U.M., Ko C.W., Willinger M. Maternal age and the risk of stillbirth throughout pregnancy in the United States. Am. J. Obstet. Gynecol. 2006, 195:764-770.
108. Robb L., Li R., Hartley L., Nandurkar H.H., Koentgen F., Begley C.G. Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation. Nat. Med. 1998, 4:303-308.
109. Rose G.L., Dowsett M., Mudge J.E., White J.O., Jeffcoate S.L. The inhibitory effects of danazol, danazol metabolites, gestrinone, and testosterone on the growth of human endometrial cells in vitro. Fertil. Steril. 1988, 49:224-228.
110. Sagle M., Bishop K., Ridley N., Alexander F.M., Michel M., Bonney R.C., Beard R.W., Franks S. Recurrent early miscarriage and polycystic ovaries. BMJ 1988, 297:1027-1028.
111. Salonia A., Pontillo M., Nappi R.E., Zanni G., Fabbri F., Scavini M., Daverio R., Gallina A., Rigatti P., Bosi E., Bonini P.A., Montorsi F. Menstrual cycle-related changes in circulating androgens in healthy women with self-reported normal sexual function. J. Sex Med. 2008, 5:854-863.
112. Sasaki M., Oh B.R., Dharia A., Fujimoto S., Dahiya R. Inactivation of the human androgen receptor gene is associated with CpG hypermethylation in uterine endometrial cancer. Mol. Carcinog. 2000, 29:59-66.
113. Schaufele F., Carbonell X., Guerbadot M., Borngraeber S., Chapman M.S., Ma A.A., Miner J.N., Diamond M.I. The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions. Proc. Natl. Acad. Sci. USA 2005, 102:9802-9807.
114. Schoolcraft W.B., Katz-Jaffe M.G., Stevens J., Rawlins M., Munne S. Preimplantation aneuploidy testing for infertile patients of advanced maternal age: a randomized prospective trial. Fertil. Steril. 2009, 92:157-162.
115. Shiina H., Matsumoto T., Sato T., Igarashi K., Miyamoto J., Takemasa S., Sakari M., Takada I., Nakamura T., Metzger D., Chambon P., Kanno J., Yoshikawa H., Kato S. Premature ovarian failure in androgen receptor-deficient mice. Proc. Natl. Acad. Sci. USA 2006, 103:224-229.
116. Sikand K., Slaibi J.E., Singh R., Slane S.D., Shukla G.C. miR 488* inhibits androgen receptor expression in prostate carcinoma cells. Int. J. Cancer 2011, 129.
117. Sir-Petermann T., Maliqueo M., Angel B., Lara H.E., Perez-Bravo F., Recabarren S.E. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum. Reprod. 2002, 17:2573-2579.
118. Skjaerven R., Wilcox A.J., Lie R.T. The interval between pregnancies and the risk of preeclampsia. N. Engl. J. Med. 2002, 346:33-38.
119. Slayden O.D., Nayak N.R., Burton K.A., Chwalisz K., Cameron S.T., Critchley H.O., Baird D.T., Brenner R.M. Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium. J. Clin. Endocrinol. Metab. 2001, 86:2668-2679.
120. Snijders M.P., de Goeij A.F., Debets-Te Baerts M.J., Rousch M.J., Koudstaal J., Bosman F.T. Immunocytochemical analysis of oestrogen receptors and progesterone receptors in the human uterus throughout the menstrual cycle and after the menopause. J. Reprod. Fertil. 1992, 94:363-371.
121. Spencer J.B., Klein M., Kumar A., Azziz R. The age-associated decline of androgens in reproductive age and menopausal Black and White women. J. Clin. Endocrinol. Metab. 2007, 92:4730-4733.
122. Stewart C.L., Cullinan E.B. Preimplantation development of the mammalian embryo and its regulation by growth factors. Dev. Genet. 1997, 21:91-101.
123. Sulcova J., Hill M., Hampl R., Starka L. Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects. J. Endocrinol. 1997, 154:57-62.
124. Suvanto-Luukkonen E., Sundstrom H., Penttinen J., Kauppila A., Rutanen E.M. Insulin-like growth factor-binding protein-1: a biochemical marker of endometrial response to progestin during hormone replacement therapy. Maturitas 1995, 22:255-262.
125. Takano M., Lu Z., Goto T., Fusi L., Higham J., Francis J., Withey A., Hardt J., Cloke B., Stavropoulou A.V., Ishihara O., Lam E.W., Unterman T.G., Brosens J.J., Kim J.J. Transcriptional cross talk between the forkhead transcription factor forkhead box O1A and the progesterone receptor coordinates cell cycle regulation and differentiation in human endometrial stromal cells. Mol. Endocrinol. 2007, 21:2334-2349.
126. Tamaya T., Arabori K., Okada H. Relation between steroid receptor levels and prolactin level in the decidua of early human pregnancy. Fertil. Steril. 1985, 43:761-765.
127. Thornton J.W. Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions. Proc. Natl. Acad. Sci. USA 2001, 98:5671-5676.
128. Tierney E.P., Tulac S., Huang S.T., Giudice L.C. Activation of the protein kinase A pathway in human endometrial stromal cells reveals sequential categorical gene regulation. Physiol. Genomics 2003, 16:47-66.
129. Tyler J.P., Newton J.R., Collins W.P. The concentration of testosterone in serial samples of peripheral venous plasma from infertile women. Acta Eur. Fertil. 1975, 6:355-360.
130. Vermeulen A., Verdonck L. Plasma androgen levels during the menstrual cycle. Am. J. Obstet. Gynecol. 1976, 125:491-494.
131. Vermeulen-Meiners C., Poortman J., Nabuurs M., Thijssen J.H. The endogenous concentration and subcellular distribution of androgens in normal human premenopausal endometrium, myometrium and vagina. Gynecol. Endocrinol. 1988, 2:121-130.
132. Villavicencio A., Bacallao K., Avellaira C., Gabler F., Fuentes A., Vega M. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia. Gynecol. Oncol. 2006, 103:307-314.
133. Wu R.C., Feng Q., Lonard D.M., O'Malley B.W. SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock. Cell 2007, 129:1125-1140.
134. Yaron Y., Botchan A., Amit A., Kogosowski A., Yovel I., Lessing J.B. Endometrial receptivity: the age-related decline in pregnancy rates and the effect of ovarian function. Fertil. Steril. 1993, 60:314-318.
135. Yeap B.B., Krueger R.G., Leedman P.J. Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells. Endocrinology 1999, 140:3282-3291.
136. Yeap B.B., Voon D.C., Vivian J.P., McCulloch R.K., Thomson A.M., Giles K.M., Czyzyk-Krzeska M.F., Furneaux H., Wilce M.C., Wilce J.A., Leedman P.J. Novel binding of HuR and poly(C)-binding protein to a conserved UC-rich motif within the 3'-untranslated region of the androgen receptor messenger RNA. J. Biol. Chem. 2002, 277:27183-27192.
137. Yovich J.L., Stanger J.D., Yovich J.M., Tuvik A.I. Assessment and hormonal treatment of the luteal phase of in vitro fertilization cycles. Aust. N Z J Obstet. Gynaecol. 1984, 24:125-130.
138. Zang H., Sahlin L., Masironi B., Eriksson E., Linden Hirschberg A. Effects of testosterone treatment on endometrial proliferation in postmenopausal women. J. Clin. Endocrinol. Metab. 2007, 92:2169-2175.
139. Zang H., Sahlin L., Masironi B., Hirschberg A.L. Effects of testosterone and estrogen treatment on the distribution of sex hormone receptors in the endometrium of postmenopausal women. Menopause 2008, 15:233-239.
140. Zhang X., Croy B.A. Maintenance of decidual cell reaction by androgens in the mouse. Biol. Reprod. 1996, 55:519-524.
141. Zumoff B., Strain G.W., Miller L.K., Rosner W. Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. J. Clin. Endocrinol. Metab. 1995, 80:1429-1430.